MAPT and Alzheimer disease: Three main biomarkers have been established for the diagnosis of Alzheimer’s disease (AD): (1) biomarkers of amyloid-beta (Aβ) plaques; (2) biomarkers of fibrillar tau; and (3) biomarkers of neurodegeneration [1].